{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:50:21Z","timestamp":1792651821225,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver Transpl."],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Approximately 80% of patients with primary sclerosing cholangitis (PSC) also have inflammatory bowel disease (IBD), and its effect on the outcomes of liver transplantation (LT) for PSC is unclear. We retrospectively collected data from adults who underwent LT for PSC from 1989 to January 2018 in 4 French LT centers. We compared the rates of patient and graft survivals and of complications after LT. Among 87 patients, 52 (60%) had preexisting IBD. Excluding those who died within the first 3\u00a0months, the 10\u2010year patient survival and graft survival rates were 92.6% (95% confidence interval [CI], 84.3%\u2010100%) and 77.1% (53.8%\u201085.3%), respectively, in the PSC with IBD (PSC\u2010IBD) group and 97.1% (91.4%\u2010100%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.44) and 83.2% (69.6%\u201096.9%; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.43) in the isolated PSC group, respectively. Exposure to azathioprine after LT was significantly associated with mortality (odds ratio [OR], 15.55; 1.31\u2010184.0; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.03), whereas exposure to mycophenolate mofetil was associated with improved survival (OR, 0.17; 95% CI, 0.04\u20100.82; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.03), possibly an era effect. The rate of recurrent PSC was 21% in the PSC\u2010IBD group and 11% in the isolated PSC group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.24). Severe infections occurred in 125 per 1000 person\u2010years in both groups. Exposure to mycophenolate mofetil was associated with a lower risk of infection (OR, 0.26; 95% CI, 0.08\u20100.85; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.03). The presence of IBD was associated with cytomegalovirus (CMV) infection (OR, 3.24; 95% CI, 1.05\u20109.98; <jats:italic toggle=\"yes\">P<\/jats:italic>\u00a0=\u00a00.04). IBD prior to LT for PSC may not affect patient or transplant survival but may increase the risk of CMV infection.<\/jats:p>","DOI":"10.1002\/lt.25838","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:19:19Z","timestamp":1593530359000},"page":"1477-1491","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis"],"prefix":"10.1097","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1487-7287","authenticated-orcid":false,"given":"Marie","family":"Irl\u00e8s\u2010Dep\u00e9","sequence":"first","affiliation":[{"name":"Service d\u2019H\u00e9patologie,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1064-0621","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Roullet","sequence":"additional","affiliation":[{"name":"Service de Chirurgie H\u00e9patobiliaire,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-9139","authenticated-orcid":false,"given":"Martine","family":"Neau\u2010Cransac","sequence":"additional","affiliation":[{"name":"Service de Chirurgie H\u00e9patobiliaire,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-5396","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[{"name":"Service de Gastro\u2010Ent\u00e9rologie, H\u00f4pital Haut\u2010L\u00e9v\u00eaque,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8262-5607","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Dharancy","sequence":"additional","affiliation":[{"name":"Service d\u2019Anesth\u00e9sie\u2010R\u00e9animation Uro\u2010Vasculaire et Transplantation R\u00e9nale,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-9810","authenticated-orcid":false,"given":"Pauline","family":"Houssel\u2010Debry","sequence":"additional","affiliation":[{"name":"F\u00e9d\u00e9ration des Sp\u00e9cialit\u00e9s Digestives,H\u00f4pital Edouard Herriot, Hospices Civils de Lyon,Lyon,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5819-6312","authenticated-orcid":false,"given":"Olivier","family":"Boillot","sequence":"additional","affiliation":[{"name":"Service de Gastro\u2010Ent\u00e9rologie, H\u00f4pital Haut\u2010L\u00e9v\u00eaque,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-2476","authenticated-orcid":false,"given":"Laurence","family":"Chiche","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9patologie,H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire de Lille,Lille,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-6349","authenticated-orcid":false,"given":"Christophe","family":"Laurent","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9patologie,H\u00f4pital Claude Huriez, Centre Hospitalier Universitaire de Lille,Lille,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4753-6676","authenticated-orcid":false,"given":"David","family":"Laharie","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9patologie,H\u00f4pital Pont\u2010Chaillou, Centre Hospitalier Universitaire de Rennes,Rennes,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6414-1951","authenticated-orcid":false,"given":"Victor","family":"De L\u00e9dinghen","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9patologie,H\u00f4pital Pellegrin, Centre Hospitalier Universitaire de Bordeaux,Bordeaux,France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"lt25838-bib-0001-20240115","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cgh.2013.02.016","article-title":"Primary sclerosing cholangitis: diagnosis, prognosis, and management","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt25838-bib-0002-20240115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long\u2010term inflammatory bowel disease","volume":"151","year":"2016","journal-title":"Gastroenterology"},{"key":"lt25838-bib-0003-20240115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","year":"1989","journal-title":"Hepatology"},{"key":"lt25838-bib-0004-20240115","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population\u2010based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"lt25838-bib-0005-20240115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases\u2014an analysis of the UNOS database","volume":"14","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"lt25838-bib-0006-20240115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"key":"lt25838-bib-0007-20240115","first-page":"3171","article-title":"Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients","volume":"28","year":"2018","journal-title":"World J Gastroenterol"},{"key":"lt25838-bib-0008-20240115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"lt25838-bib-0009-20240115","first-page":"144","article-title":"ECCO\u2010ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"1","year":"2019","journal-title":"J Crohns Colitis"},{"key":"lt25838-bib-0010-20240115","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel","volume":"31","year":"2000","journal-title":"Hepatology"},{"key":"lt25838-bib-0011-20240115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post\u2010liver transplantation for primary sclerosing cholangitis","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"lt25838-bib-0012-20240115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long\u2010term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","year":"1999","journal-title":"Hepatology"},{"key":"lt25838-bib-0013-20240115","article-title":"Maintenance immunosuppression for adults undergoing liver transplantation: a network meta\u2010analysis","volume":"31","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"lt25838-bib-0014-20240115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.12659\/AOT.889299","article-title":"Mycophenolate mofetil in liver transplantation: a review","volume":"18","year":"2013","journal-title":"Ann Transplant"},{"key":"lt25838-bib-0015-20240115","first-page":"6211","article-title":"Bacterial infection after liver transplantation","volume":"28","year":"2014","journal-title":"World J Gastroenterol"},{"key":"lt25838-bib-0016-20240115","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ecco-jcc\/jjx057","article-title":"Safety of anti\u2010TNF treatment in liver transplant recipients: a systematic review and meta\u2010analysis","volume":"11","year":"2017","journal-title":"J Crohns Colitis"},{"key":"lt25838-bib-0017-20240115","first-page":"2034","article-title":"Latent cytomegalovirus infection exacerbates experimental colitis","volume":"1","year":"2009","journal-title":"Am J Pathol"},{"key":"lt25838-bib-0018-20240115","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"key":"lt25838-bib-0019-20240115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re\u2010evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"lt25838-bib-0020-20240115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","year":"2008","journal-title":"Transpl Int"},{"key":"lt25838-bib-0021-20240115","first-page":"1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"7","year":"2012","journal-title":"World J Gastroenterol"},{"key":"lt25838-bib-0022-20240115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"lt25838-bib-0023-20240115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre study","volume":"53","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"lt25838-bib-0024-20240115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.1840220213","article-title":"Liver transplantation for sclerosing cholangitis","volume":"22","year":"1995","journal-title":"Hepatology"},{"key":"lt25838-bib-0025-20240115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/MIB.0000000000000830","article-title":"Impact of de novo and preexisting inflammatory bowel disease on the outcome of orthotopic liver transplantation","volume":"22","year":"2016","journal-title":"Inflamm Bowel Dis"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.25838","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lt.25838","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lt.25838","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/lt.25838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T02:11:08Z","timestamp":1705284668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/lt.25838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.25838","relation":{},"ISSN":["1527-6465","1527-6473"],"issn-type":[{"value":"1527-6465","type":"print"},{"value":"1527-6473","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"2020-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}